Testing effectiveness (Phase 2)Ended earlyNCT02230930
What this trial is testing
Treatment of Apomorphine-induced Skin Reactions: a Pilot Study
Who this might be right for
Parkinson's DiseaseApomorphine-induced Skin Reactions
University Medical Center Groningen 13